Hamid, Kardo .
HRN: 21-35-28 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/05/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/05/2022
10/12/2022
IV
65mg
Q8hours
AGE With Severe Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes